330 related articles for article (PubMed ID: 9788779)
1. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
Grisel JE; Farrier DE; Wilson SG; Mogil JS
Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
[TBL] [Abstract][Full Text] [Related]
2. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
[TBL] [Abstract][Full Text] [Related]
3. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
Chiou LC
Br J Pharmacol; 1999 Sep; 128(1):103-7. PubMed ID: 10498840
[TBL] [Abstract][Full Text] [Related]
4. [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord.
Xu IS; Wiesenfeld-Hallin Z; Xu XJ
Neurosci Lett; 1998 Jun; 249(2-3):127-30. PubMed ID: 9682833
[TBL] [Abstract][Full Text] [Related]
5. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
Kapusta DR; Chang JK; Kenigs VA
J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
[TBL] [Abstract][Full Text] [Related]
6. Evidence that [Phe1 psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord.
Carpenter KJ; Dickenson AH
Br J Pharmacol; 1998 Nov; 125(5):949-51. PubMed ID: 9846631
[TBL] [Abstract][Full Text] [Related]
7. Effect of nociceptin and [Phe1psi (CH2-NH) Gly2]-nociceptin-(1-13)-NH2 on tonic activity of rat hypothalamic neurons.
Yakimova KS; Pierau FK
Neurosci Lett; 1999 Oct; 274(2):87-90. PubMed ID: 10553944
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
Ichikawa D; Ozaki S; Azuma T; Nambu H; Kawamoto H; Iwasawa Y; Takeshima H; Ohta H
Neuroreport; 2001 Jun; 12(8):1757-61. PubMed ID: 11409754
[TBL] [Abstract][Full Text] [Related]
9. Functional blockade of opioid analgesia by orphanin FQ/nociceptin.
King M; Chang A; Pasternak GW
Biochem Pharmacol; 1998 May; 55(9):1537-40. PubMed ID: 10076548
[TBL] [Abstract][Full Text] [Related]
10. Orphanin FQ/nociceptin and [Phe(1)Psi(CH(2)-NH)Gly(2)] nociceptin(1-13)-NH(2) stimulate gastric motor function in anaesthetized rats.
Krowicki ZK; Kapusta DR; Hornby PJ
Br J Pharmacol; 2000 Aug; 130(7):1639-45. PubMed ID: 10928969
[TBL] [Abstract][Full Text] [Related]
11. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
[TBL] [Abstract][Full Text] [Related]
12. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor.
Butour JL; Moisand C; Mollereau C; Meunier JC
Eur J Pharmacol; 1998 May; 349(1):R5-6. PubMed ID: 9669489
[TBL] [Abstract][Full Text] [Related]
13. The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro.
Chu X; Xu N; Li P; Wang JQ
Eur J Pharmacol; 1999 Jan; 364(1):49-53. PubMed ID: 9920184
[TBL] [Abstract][Full Text] [Related]
14. [Phe1phi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells.
Olianas MC; Maullu C; Ingianni A; Onali P
Neuroreport; 1999 Apr; 10(5):1127-31. PubMed ID: 10321496
[TBL] [Abstract][Full Text] [Related]
15. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
[TBL] [Abstract][Full Text] [Related]
16. Modulation of vestibular function by nociceptin/orphanin FQ: an in vivo and in vitro study.
Sulaiman MR; Niklasson M; Tham R; Dutia MB
Brain Res; 1999 May; 828(1-2):74-82. PubMed ID: 10320726
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG
Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105
[TBL] [Abstract][Full Text] [Related]
18. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory activity of orphanin FQ/nociceptin on traumatic rats.
Zhao H; Wu GC; Cao XD
Acta Pharmacol Sin; 2002 Apr; 23(4):343-8. PubMed ID: 11931711
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
